AtaiBeckley (ATAI) Cash & Equivalents (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Cash & Equivalents came in at $43.1 million in Q1 2026, down 49.47% quarter-over-quarter from $85.3 million in Q4 2025.
AtaiBeckley (ATAI) Cash & Equivalents (2020 - 2026) Analysis & Trends
AtaiBeckley's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $43.1 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents changed N/A year-over-year to $43.1 million in Q1 2026; TTM through Mar 2026 was $43.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $85.3 million, up 387.29% from the prior year.
- Cash & Equivalents fell to $43.1 million in Q1 2026 per ATAI's latest filing, from $85.3 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $453.6 million in Q2 2021 to a low of $17.5 million in Q4 2024.
- A 5-year average of $137.5 million and a median of $84.1 million in 2022 frame the typical range for Cash & Equivalents.
- Biggest YoY gain for Cash & Equivalents was 387.29% in 2025; the steepest drop was 387.29% in 2025.
- Year by year, Cash & Equivalents stood at $17.5 million in 2024, then jumped by 387.29% to $85.3 million in 2025, then slumped by 49.47% to $43.1 million in 2026.
- Per Business Quant, the three latest ATAI Cash & Equivalents figures stand at $43.1 million (Q1 2026), $85.3 million (Q4 2025), and $17.5 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | 30.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.10 Mn |
| Dec 31, 2025 | 85.30 Mn |
| Sep 30, 2025 | 30.40 Mn |
| Jun 30, 2025 | 61.94 Mn |
| Mar 31, 2025 | 48.29 Mn |
| Dec 31, 2024 | 17.51 Mn |
| Dec 31, 2024 | 17.51 Mn |
| Sep 30, 2024 | 44.96 Mn |
| Jun 30, 2024 | 34.33 Mn |
| Mar 31, 2024 | 33.87 Mn |
| Dec 31, 2023 | 45.03 Mn |
| Sep 30, 2023 | 76.49 Mn |
| Jun 30, 2023 | 141.10 Mn |
| Mar 31, 2023 | 185.89 Mn |
| Dec 31, 2022 | 190.61 Mn |
| Sep 30, 2022 | 142.54 Mn |
| Jun 30, 2022 | 84.13 Mn |
| Mar 31, 2022 | 123.98 Mn |
| Dec 31, 2021 | 362.27 Mn |
| Sep 30, 2021 | 430.31 Mn |